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Abstract A metabolite of homocysteine (Hcy), the thioester
Hcy thiolactone, damages proteins by modifying their lysine
residues which may underlie Hcy-associated cardiovascular
disease in humans. A protein component of high density
lipoprotein, Hcy thiolactonase (HTase) hydrolyzes thiolactone
to Hcy. Thiolactonase is a product of the polymorphic PON1
gene, also involved in detoxification of organophospates and
implicated in cardiovascular disease. Polymorphism in PON1
affects the detoxifying activity of PON1 in a substrate-
dependent manner. However, how PON1 polymorphism affects
HTase activity is unknown. Here we report a strong association
between the thiolactonase activity and PON1 genotype in human
populations. High thiolactonase activity was associated with L55
and R192 alleles, more frequent in blacks than in whites. Low
thiolactonase activity was associated with M55 and Q192 alleles,
more frequent in whites than in blacks. High thiolactonase
activity afforded better protection against protein homocystei-
nylation than low thiolactonase activity. These results suggest
that variations in HTase may play a role in Hcy-associated
cardiovascular disease. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Elevated serum homocysteine (Hcy) is an independent risk
factor for cardiovascular disease in humans [1,2]. Although
the exact mechanism of Hcy toxicity is unknown, it is believed
that Hcy or its metabolite adversely a¡ects vascular endothe-
lium whose damage is a hallmark of atherosclerosis [3]. We
have de¢ned a highly speci¢c chemical mechanism by which
Hcy can adversely a¡ect cell function [4^8]: Hcy is ¢rst con-
verted by methionyl-tRNA synthetase to Hcy thiolactone [9^
12]) which then reacts with lysine residues in proteins, damag-
ing their structure and impairing their physiological activities
[7]. The extent of Hcy thiolactone synthesis and protein ho-
mocysteinylation in human vascular endothelial cells depend
on levels of Hcy, Met, folate and high density lipoprotein
(HDL) [8], known to be linked to vascular disease [1^3].
Human serum Hcy thiolactonase (HTase), a component of
HDL, hydrolyzes Hcy thiolactone to Hcy [13]. HTase also
hydrolyzes the organophosphate paraoxon and is identical
with paraoxonase [13], a product of the PON1 gene [14].
Hcy thiolactone is a likely natural substrate of HTase/para-
oxonase [13]. Paraoxonase can also act on oxidized phospo-
holipids from low density lipoprotein [20]. Human PON1 has
several genetic polymorphisms [15], two of which result in
amino acid substitutions at positions 55 and 192 in PON1
proteins [16,17]. E¡ects of these polymorphisms on the hydro-
lysis of organophosphates, aryl esters and nerve gases (sarin,
soman) are substrate-dependent. For example, the R192 and
Q192 isoforms exhibit high and low activity, respectively, with
paraoxon, but low and high activity, respectively, with sarin;
and do not a¡ect the activity toward phenyl acetate [18]. Para-
oxonase protects against atherosclerosis in a mouse model [19]
and PON1 polymorphisms are implicated in human cardio-
vascular disease [20].
However, how these polymorphisms a¡ect HTase activity is
unknown. As a ¢rst step towards assessing its role in Hcy-
associated vascular disease, we examined HTase activities and
genotypes in human populations. We report that high HTase
activity was associated with L55 and R192 alleles, more prev-
alent in blacks than in whites, whereas low HTase activity was
associated with M55 and Q192 alleles, more prevalent in
whites than in blacks. We also found that the high activity
form of HTase a¡ords a better protection against protein
homocysteinylation than the low activity form.
2. Materials and methods
2.1. Human subjects
The subjects (Table 1) were young healthy recruits from a longitu-
dinal study of blood pressure regulation [21]. They were admitted to
an in-patient research facility (General Clinical Research Center) the
night before. The young age avoids potential confounding e¡ects as-
sociated with adult subjects. Fasting blood samples were obtained the
following morning at 07.00 h while subjects were still recumbent.
Serum [13] for enzymatic assays and DNA [22] for genotyping were
prepared from the blood obtained from the subjects via venipuncture
with informed consent.
2.2. Enzyme assays
Hydrolysis rates of 1 mM [35S]Hcy thiolactone and 1 mM paraoxon
were determined as described [13]. These rates were corrected for non-
enzymatic hydrolysis of substrates which was determined by inactivat-
ing HTase with 5 mM EDTA/2 mM D-penicillamine [13]. 1 U of
HTase is de¢ned as the amount of enzyme capable of hydrolyzing
100 nmol [35S]Hcy thiolactone to [35S]Hcy within 30 min at 37‡C.
1 U of paraoxonase is de¢ned as the amount of enzyme that will
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hydrolyze paraoxon to p-nitrophenol at a rate of 0.001A412 U/ml of
p-nitrophenol per 10 min at 25‡C.
2.3. Genotyping
Genotypes of the 55 and 192 PON1 alleles [17] were determined as
described. DNA was prepared from peripheral white blood cells using
a standard procedure [21]. Polymerase chain reaction ampli¢cations
were carried out using the following DNA primers: forward 192 prim-
er 5P-TATTGTTGCTGTGGGACCTGAG-3P, the reverse 192 primer
5P-CACGCTAAACCCAAATACATCTC-3P, the forward 55 primer
5P-GAAGAGTGATGTATAGCCCCAG-3P and the reverse 55 primer
5P-TTTAATCCAGAGCTAATGAAAGCC-3P. The ampli¢cation re-
actions (40 cycles) used REDTaqDNA Polymerase (Sigma). For al-
leles 192 each cycle included 60 s at 94‡C, 30 s at 65‡C, and 60 s at
72‡C. For alleles 55 each cycle included 45 s at 94‡C, 45 s at 61‡C,
and 45 s at 72‡C. Reactions were denatured with 0.4 M NaOH, 25
mM EDTA at 94‡C for 5 min. Nytran membranes were blotted and
then heated at 80‡C for 1 h under vacuum. Allele-speci¢c hybridiza-
tion was performed using the following end-labeled probes: Q192-
speci¢c 5P-CCTACTTACAATCCTGGG-3P, R192-speci¢c 5P-CCTA-
CTTACGATCCTGGG-3P, M55-speci¢c 5P-CTGAAGACATGGA-
GATA-3P and L55-speci¢c 5P-CTGAAGACTTGGAGATA-3P. Mem-
branes were pre-hybridized for 1 h at 42‡C, then hybridized overnight
at 55‡C for alleles 192 or at 43‡C for alleles 55. Blotted probes were
washed for 5 min at room temperature in 2USSC and 0.5% SDS
(1USSC for Q192) and for 5 min at 40‡C.
2.4. Statistics
The two-sample t-test was used to compare age and enzyme activity
levels between the black and white cohorts and to examine for gender
di¡erences. The Cochran^Mantel^Haenszel test of association was
used to examine for linkage disequilibrium between the 55 and 192
PON1 alleles. The exact Cochran^Armitage trend test [24] was used to
examine for racial di¡erences in the distributions of the 55 and 192
PON1 alleles. All analysis of HTase and paraoxonase activity levels
was done on the logarithmic scale to equalize variances. Three-way
analysis of variance was used to examine for genotype and gender
e¡ects. Both genotype e¡ects were modeled as three-level categorical
factors. Adjusted means and their standard errors (S.E.M.) are re-
ported in Table 3. In Table 3, we have included the exponentiated
adjusted means to bring the results back to the original scale.
3. Results
3.1. Frequencies of HTase/paraoxonase polymorphisms
A description of the study population is presented in Table
1. The genotype distributions of HTase/paraoxonase polymor-
phisms were determined in 67 young subjects. The frequencies
of the 55 PON1 polymorphism were 3.0% MM, 30.3% ML,
66.7% LL in blacks and 14.7% MM, 38.2% ML, 47.1% LL in
whites (P = 0.06). The frequencies of the 192 PON1 polymor-
phism were 12.1% QQ, 48.5% QR, 39.4% RR in blacks and
44.1% QQ, 52.9% QR, 2.9% RR in whites (P6 0.0001). The
55 and 192 PON1 alleles were in the Hardy^Weinberg equi-
librium [23] in each race group (P = 0.02). There was a mar-
ginal evidence for linkage disequilibrium of the 55 with the
192 allele in the whites (P = 0.0515) but none in the blacks
(P = 0.543).
The frequencies of the 55 and 192 genotypes in blacks were
not studied before. The frequencies of the 192QQ and 192RR
genotypes in blacks reported here are similar to the frequen-
cies of associated phenotypes in other black populations [16].
The frequencies of the 55 and 192 PON1 alleles in whites
reported here are similar to those observed in other white
populations [16,17]. Altogether, frequencies of the L55 and
R192 alleles in the black population (0.82 L55 and 0.64
R192) were higher than in the white population (0.64 L55
and 0.29 R192). This results in 67 and 39% of black individ-
uals being homozygous for the L55 and R192 forms, respec-
tively, compared with 47 and 3%, respectively, of white indi-
viduals. Conversely, only 3 and 12% of blacks were
homozygous for the M55 and Q192 forms, respectively, com-
pared with 15 and 44% of whites (Table 2). The di¡erences in
allele distribution between blacks and whites were highly sig-
ni¢cant for the 192 alleles (P6 0.0001) and marginally signi¢-
cant for the 55 alleles (P = 0.06).
3.2. Variations in HTase activity
We also determined the rates of Hcy thiolactone hydrolysis
in relation to the rates of paraoxon hydrolysis by HTase/para-
oxonase in sera from black and white young volunteers. There
was about ¢ve-fold variation in serum HTase activity in these
populations, which paralleled the variation in serum paraox-
onase activity (Fig. 1). Plots of the HTase activity against the
paraoxonase activity showed a positive correlation between
the two activities (r = 0.89), similar for blacks (Fig. 1A) and
whites (Fig. 1B). The HTase versus paraoxonase plots are
uniphasic (Fig. 1), in contrast to the triphasic plots of chloro-
pyrifos-oxonase versus paraoxonase, arylesterase versus para-
oxonase, diazooxonase versus paraoxonase, somanase versus
paraoxonase, and sarinase versus paraoxonase [18]. It is un-
clear whether the uniphasic nature of the HTase versus para-
oxonase plot is speci¢c for the natural substrate Hcy thiolac-
tone, or re£ects population di¡erences between the two
studies.
Table 1
Description of subjects
Blacks (n = 33) Whites (n = 34) P-value
Gender (M/F) 14/19 14/20 1.000
Age (years) 15.8 þ 2.9 18.0 þ 3.6 0.0077
HTase (U) 13.7 þ 4.1 9.9 þ 3.5 0.0001
Paraoxonase (U) 243.2 þ 108.0 143.8 þ 93.3 0.0001
Values are presented as mean þ S.D. Fisher’s exact test was used for gender and the two-sample t-test for the remainder.
Table 2
Racial distributions of the 55 and 192 alleles of PON1
Population 55MM 55ML 55LL 192QQ 192QR 192RR
Black 1 (3.0%) 10 (30.3%) 22 (66.7%) 4 (12.1%) 16 (48.5%) 13 (39.4%)
White 5 (14.7%) 13 (38.2%) 16 (47.1%) 15 (44.1%) 18 (52.9%) 1 (2.9%)
The distributions of 55 and 192 alleles showed a marginally signi¢cant (P = 0.06) and signi¢cant (P6 0.0001) di¡erence, respectively, between
blacks and whites. Values listed in parentheses are percentages within a racial group.
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3.3. Associations between HTase activity and PON1 genotype
As shown in Table 3, high HTase activity, was associated
with the L55 (P = 0.0027 and 0.0056 for blacks and whites,
respectively) and R192 alleles (P = 0.0005 and 0.0127 for
blacks and whites, respectively). Low HTase activity was as-
sociated with the M55 and Q192 alleles in both races. Blacks
were more likely than whites to have the high activity L55 and
R192 alleles (P = 0.0001). Conversely, whites were more likely
than blacks to have the low activity M55 and Q192 alleles
(Table 3). Because the di¡erences in HTase activity between
individuals were rather large (up to ¢ve-fold), our analysis of
the associations between HTase activity and genotypes
reached statistical signi¢cance with a relatively small number
of subjects (Tables 1^3). For none of the models was gender a
signi¢cant predictor (Ps 0.37).
Similar associations were also observed between the para-
oxonase activity and PON1 genotypes in blacks and whites
(not shown), consistent with other studies [16]. Thus, although
e¡ects of PON1 genotypes on activity are substrate-dependent
in most cases [18], the genotype^activity relationships are
identical for HTase and paraoxonase, explaining a positive
correlation between the two activities (Fig. 1).
3.4. HTase accelerates Hcy thiolactone turnover and minimizes
protein homocysteinylation
To assess a possible signi¢cance of the variation in HTase
levels in humans, the turnover of Hcy thiolactone was studied
in sera from the 55LL/192RR (high activity) and 55MM/
192QQ (low activity) donors. As shown in Fig. 2A, in sera
from the high activity HTase donors, Hcy thiolactone (half
life of 0.5 h) disappeared about twice as fast as in sera from
the low activity HTase donors (half life of 1.0 h). When
HTase activity was inactivated in either serum by the supple-
mentation with EDTA and D-penicillamine [13], Hcy thiolac-
tone disappeared more slowly, with a half life of 1.5 h (Fig.
2A). The disappearance of thiolactone was accompanied by a
progressive accumulation of Hcy (Fig. 2B) and Hcy-protein
(Fig. 2C) in relative amounts depending on the level of HTase
Fig. 1. Population distribution plots of HTase versus paraoxonase activities by race and genotype. A, C: Blacks. B, D: Whites. Polymorphisms
of the 192 allele (A, B) and the 55 allele (C, D) are indicated.
Table 3
Adjusted means ( þ S.E.M.) of the logarithm of HTase activity levels for di¡erent PON1 alleles
PON1 Allele Blacks Whites
adjusted mean adjusted original scale P-value adjusted mean adjusted original scale P-value
55MM 1.63 (n = 1) 5.12 0.0027 1.96 þ 0.13 (n = 5) 7.12 0.0056
55ML 2.56 þ 0.08 (n = 10) 12.94 2.10 þ 0.08 (n = 13) 8.16
55LL 2.61 þ 0.05 (n = 22) 13.64 2.41 þ 0.07 (n = 16) 11.16
192QQ 2.27 þ 0.12 (n = 4) 9.69 0.0005 2.05 þ 0.07 (n = 15) 7.74 0.0127
192QR 2.45 þ 0.06 (n = 16) 11.57 2.36 þ 0.07 (n = 18) 10.56
192RR 2.81 þ 0.07 (n = 13) 16.53 2.56 þ 0.2 (n = 1) 12.95
Adjusted means were calculated using the log-transformed data. These were exponentiated to obtain adjusted values on the original scale. The
P-values are adjusted for gender and the other genotype.
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activity in serum. More Hcy and less Hcy-protein accumu-
lated in sera from high HTase activity donors than in sera
from low HTase activity donors. The high activity form of
HTase a¡orded much better protection against protein homo-
cysteinylation than the low activity form (Fig. 2C).
For comparison, we have also analyzed Hcy thiolactone
turnover in rabbit serum, known to possess the highest levels
of HTase activity among vertebrates [6,7,13]. Hcy thiolactone
(half life of 15 min) disappeared twice as fast in rabbit serum
than in human serum from the 55LL/192RR HTase donors
(half life of 30 min) (Fig. 2A). More Hcy and less Hcy-protein
accumulated in rabbit serum than in human serum from the
55LL/192RR HTase donor. Thus, rabbit serum HTase a¡ords
much better protection against protein homocysteinylation
than human serum HTase.
4. Discussion
This work shows that (1) there is an important variation in
HTase activity in human beings; (2) high HTase activity is
associated with L55 and R192 PON1 alleles, low HTase ac-
tivity is associated with M55 and Q192 PON1 alleles ; (3) there
are large di¡erences in the genotype frequencies in black and
white human populations, explaining the di¡erences in HTase
activity levels ; (4) the HTase activity correlates with the para-
oxonase activity in both populations and (5) high activity
forms of HTase a¡ord better protection against protein
homocysteinylation than low activity forms. These data sug-
gest that HTase activity/genotype may have relevance to a
risk for Hcy-linked cardiovascular disease in human popula-
tions.
The mechanisms underlying the association between Hcy
and cardiovascular diseases are unclear. One possible mecha-
nism involves metabolic conversion of Hcy to Hcy thiolactone
and protein homocysteinylation by Hcy thiolactone, which
results in protein damage [7]. The presence in human beings
of a HDL-associated HTase which hydrolyzes Hcy thiolac-
tone [13] supports this mechanism. The variation in HTase
activity and the association of high activity with speci¢c
PON1 alleles (L55 and R192) in human populations, de-
scribed in this study, suggest that HTase activity and/or geno-
type might be important factors in Hcy-associated vascular
disease. However, because the distributions of HTase activity
within genotypes overlap (Fig. 1), HTase activity might be a
better predictor than the PON1 genotype. High HTase activ-
ity a¡ords better protection against protein homocysteinyla-
tion than low HTase activity (Fig. 2). Although Hcy-protein is
present in human serum [5] it is unknown how the levels of
Hcy-protein correlate with HTase levels.
Higher HTase activity and a greater frequency of high ac-
tivity PON1 alleles in blacks than in whites are striking, but
correlate well with higher HDL levels in blacks compared
with whites. Thus, blacks, in addition to more favorable lipid
pro¢les [25], appear to have also more favorable Hcy thiolac-
tone metabolism. However, associations between Hcy and
myocardial infarction are similar among blacks and whites
[2], which suggests that environmental factors may be remov-
ing any natural advantage that blacks may have.
Because paraoxonase may remove lipid peroxidation prod-
ucts, numerous studies examined a possible relationship be-
tween PON1 polymorphisms and coronary heart disease [20].
The R192 allele was associated with an increased risk for
cardiovascular disease in some populations at high risk [15],
but not in populations at large [26]. It has been suggested that
paraoxonase activity may be a better predictor for cardiovas-
cular disease or organophosphate susceptibility than the geno-
type alone [27].
Our present data lead us to hypothesize that low HTase
activity may be a risk factor in populations with elevated
Hcy levels. No clinical studies have yet examined relationships
between HTase activity and cardiovascular disease. However,
two recent clinical studies support our hypothesis that the low
activity HTase/paraoxonase alleles (Q192 and M55), com-
bined with elevated Hcy, may predispose humans to cardio-
vascular disease. In one clinical trial [28], the Q192 allele of
PON1 was associated with the extent of coronary artery dis-
ease in human subjects homozygous for the methylenetetrahy-
drofolate reductase T677 genotype (i.e. having elevated Hcy
levels). In another study [29], Finnish subjects homozygous
for the low activity M55 paraoxonase allele were about three
Fig. 2. Turnover of Hcy thiolactone in serum. Serum was spiked with 3.5 WM [35S]Hcy thiolactone (20 000 Ci/mol) and incubated at 37‡C for
up to 3 h. At indicated time intervals, aliquots of 35S-labeled serum were diluted four-fold with 5 mM dithiothreitol and Hcy thiolactone and
the products of its turnover, Hcy and Hcy-protein, were separated by thin layer chromatography on cellulose plates (Analtech) [13]. Kinetics of
disappearance of Hcy thiolactone (A), formation of Hcy (B) and Hcy-protein (C) in human serum from high HTase activity donors (genotype
LL55/RR192; F), low HTase activity donors (genotype MM55/QQ192; 8), rabbit serum (E), and in human sera in which HTase was inacti-
vated by supplementation with 5 mM EDTA and 2 mM D-penicillamine (b) are shown.
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times more likely than the high activity L55 homozygotes to
su¡er a myocardial infarction. Although not examined in that
study [29], Hcy levels in Finns are known to be the highest
among populations in industrialized countries, as is the prev-
alence of cardiovascular disease mortality [30]. These obser-
vations underline the importance of examining the variability
of HTase and protein homocysteinylation in future studies of
associations between Hcy and vascular diseases in human
populations.
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